Labiotech.eu - Europe's leading Biotech News Website

Latest Posts

Podcast 18 Jul 2025

Taking the fight to inflammatory disease: InflaRx’s first-in-class C5a/C5aR signaling pathway strategy

This week, I talked to Niels Riedemann, CEO and Founder of InflaRx, about his company’s first-in-class approach to fighting inflammation.

July 18, 2025

sickle cell disease treatment

In Depth 17 Jul 2025

New horizons in sickle cell disease treatment: Promising therapies on the way

Discover the current pipeline candidates advancing through the clinic for the treatment of sickle cell disease.

July 17, 2025 - 9 minutesmins - By Willow Shah-Neville

Rare autoimmune diseases

In Depth 16 Jul 2025

Eight rare autoimmune diseases biotechs are fighting to treat

Discover eight rare autoimmune diseases you may not have heard of and what biotechs are doing to treat them.

July 16, 2025 - 12 minutesmins - By Willow Shah-Neville

Concentra Biosciences

News and Trends 15 Jul 2025

Serial acquirer Concentra Biosciences on a buyout spree in 2025

Concentra Biosciences is buying struggling biotechs and its portfolio has been growing rapidly in 2025. Learn about what it has been up to this past year.

July 15, 2025 - 7 minutesmins - By Roohi Mariam Peter

biotech books

Best in Biotech 14 Jul 2025

Top biotech books of all time

Here are 51 great biotech books for this summer 2025 that are bound to get you hooked. From sci-fi to the nitty-gritties of biotech, we’ve got you covered!

July 14, 2025 - 25 minutesmins - By Roohi Mariam Peter

xoma royalty acquisitions

News and Trends 11 Jul 2025

XOMA Royalty’s acquisition of Turnstone Biologics: what do royalty deals offer the biopharma industry?

Turnstone Biologics is being acquired by royalty aggregator Xoma Royalty. Discover how royalty deals are shaping the biopharma industry.

July 11, 2025 - 9 minutesmins - By Roohi Mariam Peter

ADVERTISEMENT

Podcast 11 Jul 2025

How OMass Therapeutics is tackling congenital adrenal hyperplasia, a rare genetic disorder

This week we talk about Congenital Adrenal Hyperplasia and how OMass Therapeutics is approaching it with the company CEO, Ros Deegan.

July 11, 2025

Nuclidium and Actithera raise big in radiopharma

News and Trends 10 Jul 2025

Radiopharma’s new wave: Nuclidium and Actithera raise the stakes

Take a closer look at the radiopharma new wave as Nuclidium and Actithera raise big to develop their platforms.

July 10, 2025 - 9 minutesmins - By Jules Adam

CIPN

In Depth 9 Jul 2025

New hope for CIPN: Can emerging therapies ease chemotherapy’s nerve damage?

Delve into the growing field of CIPN, the most common side effect of chemotherapy, as we are getting closer to a first approval.

July 9, 2025 - 6 minutesmins - By Jules Adam

biotech funding june 2025

In Depth 8 Jul 2025

The biggest biotech funding rounds in June 2025

The companies Insmed, Cidara Therapeutics, and Cogent Biosciences bagged the biggest biotech funding rounds overall in June 2025.

July 8, 2025 - 4 minutesmins - By Willow Shah-Neville

Biotech in Vienna

In Depth 7 Jul 2025

Biotech in Vienna: a budding life science hub

As biotech in Vienna raked in €22.7 billion in 2023, there has been a significant increase in innovation, research, and employment in recent years.

July 7, 2025 - 9 minutesmins - By Roohi Mariam Peter

boston biotech companies

Best in Biotech 4 Jul 2025

14 biotech companies to know in the Boston area in 2025

Explore Boston’s vibrant biotech landscape with fourteen innovative companies leading the charge in life sciences research.

July 4, 2025 - 15 minutesmins - By Jules Adam

ADVERTISEMENT